Company Filing History:
Years Active: 1990-1995
Title: Riccardo Vanni: Innovator in Pharmaceutical Compositions
Introduction
Riccardo Vanni is a notable inventor based in Siena, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for oral and parenteral administration. With a total of 3 patents to his name, Vanni's work has the potential to impact the medical community positively.
Latest Patents
Vanni's latest patents include groundbreaking pharmaceutical compositions and dosage forms for oral administration. One of his notable inventions involves new pharmaceutical compositions containing calcitonin as the active principle. These compositions are designed for perbuccal and sublingual tablets, where the active principle is homogenized with a mixture of solid excipients. This innovation allows for the same pattern of hematic levels to be achieved as with conventional intramuscular administration. Another significant patent focuses on pharmaceutical compositions for parenteral use containing calcitonin. This invention features a freeze-dried pharmaceutical composition that includes a therapeutically effective amount of calcitonin and human albumin. The injectable solution derived from this composition is designed for parenteral administration, showcasing Vanni's commitment to advancing medical treatments.
Career Highlights
Throughout his career, Riccardo Vanni has worked with reputable companies such as Scalvo Spa and Sciavo S.p.a. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Vanni has collaborated with notable professionals in his field, including Filippo Lattanzi and Maurizio Cecchettin. These collaborations have likely enriched his work and expanded the scope of his inventions.
Conclusion
Riccardo Vanni's contributions to pharmaceutical compositions demonstrate his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing healthcare solutions, making him a significant figure in the field of pharmaceuticals.